NOMO2
BOS complex subunit NOMO2
Also known as: NOMO, NOMO2_HUMAN, PM5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JPE7
- Gene
- NOMO2
- Ensembl
- ENSG00000185164
- Chromosome
- 16
- Canonical length
- 1267 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a protein originally thought to be related to the collagenase gene family. This gene is one of three highly similar genes in a region of duplication located on the p arm of chromosome 16. These three genes encode closely related proteins that may have the same function. The protein encoded by one of these genes has been identified as part of a protein complex that participates in the Nodal signaling pathway during vertebrate development. Mutations in ABCC6, which is located nearby, rather than mutations in this gene are associated with pseudoxanthoma elasticum (PXE). Two transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1267 residues, UniProt reviewed canonical sequence.
>Q5JPE7|NOMO2
1 MLVGQGAGLL GPAVVTAAVV LLLSGVGPAH GSEDIVVGCG GFVKSDVEIN YSLIEIKLYT
61 KHGTLKYQTD CAPNNGYFMI PLYDKGDFIL KIEPPLGWSF EPTTVELHVD GVSDICTKGG
121 DINFVFTGFS VNGKVLSKGQ PLGPAGVQVS LRNTGTEAKI QSTVTQPGGK FAFFKVLPGD
181 YEILATHPTW ALKEASTTVR VTNSNANAAS PLIVAGYNVS GSVRSDGEPM KGVKFLLFSS
241 LVTKEDVLGC NVSPVPGFQP QDESLVYLCY TVSREDGSFS FYSLPSGGYT VIPFYRGERI
301 TFDVAPSRLD FTVEHDSLKI EPVFHVMGFS VTGRVLNGPE GDGVPEAVVT LNNQIKVKTK
361 ADGSFRLENI TTGTYTIHAQ KEHLYFETVT IKIAPNTPQL ADIVATGFSV CGRISIIRFP
421 DTVKQMNKYK VVLSSQDKDK SLVTVETDAH GSFCFKAKPG TYKVQVMVPE AETRAGLTLK
481 PQTFPLTVTD RPVMDVAFVQ FLASVSGKVS CLDTCGDLLV TLQSLSRQGE KRSLQLSGKV
541 NAMTFTFDNV LPGKYKISIM HEDWCWKNKS LEVEVLEDDV SAVEFRQTGY MLRCSLSHAI
601 TLEFYQDGNG RENVGIYNLS KGVNRFCLSK PGVYKVTPRS CHRFEQAFYT YDTSSPSILT
661 LTAIRHHVLG TITTDKMMDV TVTIKSSIDS EPALVLGPLK SVQELRREQQ LAEIEARRQE
721 REKNGNEEGE ERMTKPPVQE MVDELQGPFS YDFSYWARSG EKITVTPSSK ELLFYPPSME
781 AVVSGESCPG KLIEIHGKAG LFLEGQIHPE LEGVEIVISE KGASSPLITV FTDDKGAYSV
841 GPLHSDLEYT VTSQKEGYVL TAVEGTIGDF KAYALAGVSF EIKAEDDQPL PGVLLSLSGG
901 LFRSNLLTQD NGILTFSNLS PGQYYFKPMM KEFRFEPSSQ MIEVQEGQNL KITITGYRTA
961 YSCYGTVSSL NGEPEQGVAM EAVGQNDCSI YGEDTVTDEE GKFRLRGLLP GCVYHVQLKA
1021 EGNDHIERAL PHHRVIEVGN NDIDDVNIIV FRQINQFDLS GNVITSSEYL PTLWVKLYKS
1081 ENLDNPIQTV SLGQSLFFHF PPLLRDGENY VVLLDSTLPR SQYDYILPQV SFTAVGYHKH
1141 ITLIFNPTRK LPEQDIAQGS YIALPLTLLV LLAGYNHDKL IPLLLQLTSR LQGVGALGQA
1201 ASDNSGPEDA KRQAKKQKTR RTLRLQEEFQ LMWCLVPWRG TLGIHLFSSL PFASEILLET
1261 TATCIHYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NOMO2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 280 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 280 nTPM
- heart muscle: 175 nTPM
- basal ganglia: 160 nTPM
- cerebral cortex: 153 nTPM
- hypothalamus: 119 nTPM
- skeletal muscle: 117 nTPM
Single-cell type
- retinal amacrine cells: 21 nCPM
- plasma cells: 19 nCPM
- epicardial cells: 18 nCPM
- lactotrophs: 18 nCPM
- cardiomyocytes: 16 nCPM
- retinal ganglion cells: 16 nCPM
Immune cell
- plasmacytoid DC: 23 nTPM
- T-reg: 23 nTPM
- basophil: 22 nTPM
- total PBMC: 18 nTPM
- non-classical monocyte: 16 nTPM
- memory CD8 T-cell: 15 nTPM
Brain region
- cerebral cortex: 125 nTPM
- basal ganglia: 114 nTPM
- hypothalamus: 109 nTPM
- white matter: 88 nTPM
- pons: 83 nTPM
- medulla oblongata: 76 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.03
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Carboxypeptidase-like, regulatory domain superfamily
- Immunoglobulin-like fold
- Carbohydrate-binding-like fold
- SpaA-like, prealbumin fold domain subgroup 1
- Serine-Aspartate Repeat-Containing
- NOMO-like, ninth beta-sandwich domain
- NOMO-like, N-terminal beta-sandwich domain
- NOMO, eighth prealbumin-like domain
- NOMO, third transthyretin-like domain
- NOMO, fifth transthyretin-like domain
- NOMO, C-terminal transthyretin-like domain
- NOMO, seventh transthyretin-like domain
- Carboxypeptidase regulatory-like domain
- Prealbumin-like fold domain
- BOS complex subunit NOMO1-like, first beta sandwich domain
- BOS complex subunit NOMO1-like, beta sandwich domain
- BOS complex subunit NOMO1-like, second beta sandwich domain
- NOMO Ig-like domain
- NOMO C-terminal transthyretin-like domain
- NOMO third transthyretin-like domain
- NOMO fifth transthyretin-like domain
- NOMO eighth prealbumin-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NOMO2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NOMO2 as an antibody target. Whether an autoantibody or antibody against NOMO2 could matter depends on whether native NOMO2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NOMO2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NOMO2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...